Literature DB >> 21278322

Implementing opt-out programs at Los Angeles county jail: a gateway to novel research and interventions.

Mark Malek1, Alexander R Bazazi, Garrett Cox, Germaine Rival, Jacques Baillargeon, Armidia Miranda, Josiah D Rich.   

Abstract

Routine opt-out screening and vaccination programs are effective methods for improving public health in correctional populations. Jail-based rapid testing for HIV, hepatitis B and C, tuberculosis, syphilis, gonorrhea, and chlamydia can improve urban health by increasing diagnosis and linkage to care for infectious diseases. In addition, jail-based vaccination programs would significantly benefit community health and lower costs associated with tertiary level care. The paucity of ethical and rigorous scientific research among incarcerated populations excludes these marginalized members of society from potential advancements in correctional medicine and public health. Routine opt-out testing programs would not only benefit the health of the correctional population but also serve as platforms for future research. Trials measuring the efficacy of new rapid tests, screening methods, novel vaccine delivery systems, or accelerated vaccine regimens would be greatly beneficial.

Entities:  

Mesh:

Year:  2011        PMID: 21278322      PMCID: PMC3154702          DOI: 10.1177/1078345810385916

Source DB:  PubMed          Journal:  J Correct Health Care        ISSN: 1078-3458


  19 in total

1.  Increasing prevalence of methicillin-resistant Staphylococcus aureus infection in California jails.

Authors:  Erica S Pan; Binh A Diep; Heather A Carleton; Edwin D Charlebois; George F Sensabaugh; Barbara L Haller; Françoise Perdreau-Remington
Journal:  Clin Infect Dis       Date:  2003-10-17       Impact factor: 9.079

2.  Prisons show prophylaxis for close contacts may indeed help in next flu pandemic.

Authors:  Niyi Awofeso
Journal:  BMJ       Date:  2004-07-17

3.  The potential role of custody facilities in controlling sexually transmitted diseases.

Authors:  D Cohen; R Scribner; J Clark; D Cory
Journal:  Am J Public Health       Date:  1992-04       Impact factor: 9.308

4.  Panton-Valentine leukocidin: a marker of severity for Staphylococcus aureus infection?

Authors:  Jerome Etienne
Journal:  Clin Infect Dis       Date:  2005-07-29       Impact factor: 9.079

5.  Routine opt-out HIV testing.

Authors:  Alan R Lifson; Sarah L Rybicki
Journal:  Lancet       Date:  2007-02-17       Impact factor: 79.321

6.  The health and health care of US prisoners: results of a nationwide survey.

Authors:  Andrew P Wilper; Steffie Woolhandler; J Wesley Boyd; Karen E Lasser; Danny McCormick; David H Bor; David U Himmelstein
Journal:  Am J Public Health       Date:  2009-01-15       Impact factor: 9.308

7.  The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997.

Authors:  Theodore M Hammett; Mary Patricia Harmon; William Rhodes
Journal:  Am J Public Health       Date:  2002-11       Impact factor: 9.308

8.  Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs.

Authors:  Gary Marks; Nicole Crepaz; J Walton Senterfitt; Robert S Janssen
Journal:  J Acquir Immune Defic Syndr       Date:  2005-08-01       Impact factor: 3.731

9.  The 1918 influenza pandemic: insights for the 21st century.

Authors:  David M Morens; Anthony S Fauci
Journal:  J Infect Dis       Date:  2007-02-23       Impact factor: 5.226

10.  Frequent failed early HIV detection in a high prevalence area: implications for prevention.

Authors:  Denise F Johnson; Frank J Sorvillo; Amy R Wohl; Gordon Bunch; Nina T Harawa; Alexander Carruth; Maribel Castillon; Breska Jimenez
Journal:  AIDS Patient Care STDS       Date:  2003-06       Impact factor: 5.078

View more
  8 in total

1.  Rapid HIV testing in large urban jails.

Authors:  Curt G Beckwith; Amy Nunn; Sharon Baucom; Asresahegn Getachew; Akin Akinwumi; Bruce Herdman; Phil DiBartolo; Susan Spencer; Devon Brown; Henry Lesansky; Irene Kuo
Journal:  Am J Public Health       Date:  2012-03-08       Impact factor: 9.308

2.  Understanding interactions of formerly incarcerated HIV-positive men and transgender women with substance use treatment, medical, and criminal justice systems.

Authors:  Nina T Harawa; Bita Amani; Jane Rohde Bowers; Jennifer N Sayles; William Cunningham
Journal:  Int J Drug Policy       Date:  2017-08-09

3.  The feasibility of implementing the HIV seek, test, and treat strategy in jails.

Authors:  Curt Beckwith; Lauri Bazerman; Fizza Gillani; Liem Tran; Brita Larson; Saul Rivard; Timothy Flanigan; Josiah Rich
Journal:  AIDS Patient Care STDS       Date:  2014-03-11       Impact factor: 5.078

4.  Effectiveness of a Peer Navigation Intervention to Sustain Viral Suppression Among HIV-Positive Men and Transgender Women Released From Jail: The LINK LA Randomized Clinical Trial.

Authors:  William E Cunningham; Robert E Weiss; Terry Nakazono; Mark A Malek; Steve J Shoptaw; Susan L Ettner; Nina T Harawa
Journal:  JAMA Intern Med       Date:  2018-04-01       Impact factor: 21.873

5.  Opt-Out HIV Testing of Inmates in North Carolina Prisons: Factors Associated with not Wanting a Test and not Knowing They Were Tested.

Authors:  Catherine A Grodensky; David L Rosen; Sayaka Hino; Carol E Golin; David A Wohl
Journal:  AIDS Behav       Date:  2016-04

6.  Sexually transmitted infections among incarcerated women: findings from a decade of screening in a Los Angeles County Jail, 2002-2012.

Authors:  Marjan Javanbakht; Melina Boudov; Laura J Anderson; Mark Malek; Lisa V Smith; Michael Chien; Sarah Guerry
Journal:  Am J Public Health       Date:  2014-09-11       Impact factor: 9.308

7.  Australian health care providers' views on opt-out HIV testing.

Authors:  Stacy Leidel; Ruth McConigley; Duncan Boldy; Sally Wilson; Sonya Girdler
Journal:  BMC Public Health       Date:  2015-09-14       Impact factor: 3.295

Review 8.  Routine testing for blood-borne viruses in prisons: a systematic review.

Authors:  Caroline Rumble; David J Pevalin; Éamonn O'Moore
Journal:  Eur J Public Health       Date:  2015-07-27       Impact factor: 3.367

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.